| (210) | Number of the EPO application | 16721038 |
| (220) | Filing date of the EPO application | 2016.04.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 38/2019, 2019.09.18 |
| (110) | EPO patent number | 3288945 |
| (21) | Number of the application | e 2018 0228 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | SAVALL Bradley M., US;
SWANSON Devin M., US;
WU Dongpei, US;
AMERIKS Michael K., US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | IMIDAZOPYRAZINES AND PYRAZOLOPYRIMIDINES AND THEIR USE AS AMPA RECEPTOR MODULATORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); A61K 31/4985 (2006.01.01); A61K 31/519 (2006.01.01); A61P 25/00 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2018.04.30 |
| (30) | Priority | 201562154310 P, 2015.04.29, US |
| (86) | International application | PCT/US2016/029791, 2016.04.28 |
| (87) | International publication | WO 2016/176457, 2016.11.03 |